Pain Management Drugs Market Update 2023: Predicted to Surpass USD 91.64 Billion by 2027, Report

Pain is a complex medical condition, which not only affects physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Pain control medications help to alleviate pain through various pathways in patient’s body. There are various types of medicines available in the pain management drugs market targeting specific biomolecules in the body and manipulating specific mechanisms to avoid pain sensation. On the basis of cause of pain, the treatment provided can be simple or complex. Pain can be managed using a variety of pharmacological and non-pharmacological therapies.

Pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., Mylan NV., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc. The other prominent players in the value chain include Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim, Sorrento Therapeutics, WEX Pharmaceuticals, and Zynerba Pharmaceuticals

𝐁𝐮𝐲 𝐍𝐨𝐰 https://www.alliedmarketresearch.com/checkout-final/bca16986d3e12e151304dd7ad12382e9

The pain management drugs market can be segmented based on various factors, including the type of pain, drug class, and distribution channel. Here are some common segments within the pain management drugs market:

1. Type of Pain: a. Neuropathic Pain: Drugs specifically designed to target nerve-related pain, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. b. Musculoskeletal Pain: Drugs that alleviate pain associated with conditions like arthritis, back pain, and fibromyalgia. c. Postoperative Pain: Medications used to manage pain after surgical procedures. d. Cancer Pain: Drugs for controlling pain related to cancer, including chemotherapy-induced pain and pain caused by tumor growth.
2. Drug Class: a. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Medications that reduce pain, inflammation, and fever, such as ibuprofen, naproxen, and aspirin. b. Opioids: Strong pain relievers used for severe pain, including morphine, oxycodone, and fentanyl. c. Anticonvulsants: Medications primarily used for treating seizures but also effective for neuropathic pain, such as gabapentin and pregabalin. d. Antidepressants: Certain antidepressant medications, like amitriptyline and duloxetine, can also help alleviate chronic pain. e. Local Anesthetics: Drugs that numb specific areas to provide temporary pain relief, including lidocaine and benzocaine. f. Others: This category includes muscle relaxants, corticosteroids, and other pain management drugs with unique mechanisms of action.
3. Distribution Channel: a. Hospital Pharmacies: Pain management drugs dispensed within hospitals and healthcare facilities. b. Retail Pharmacies and Drug Stores: Over-the-counter and prescription pain medications available in pharmacies and drug stores. c. Online Pharmacies: Increasingly popular channel for purchasing pain management drugs over the internet. d. Others: This category encompasses specialty clinics, pain management centers, and mail-order pharmacies.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/404

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com